Except for the WNT3 and CHN2 genes, all examined signaling proteins in Table 1 showed increased expression in breast cancer cells incubated with both the low dose of paclitaxel (60 ng/mL) and the high dose of this drug (300 ng/mL) as compared to the control cells. This evidence concerns the gene CHN2 and breast carcinoma.